{"gene":"BCORL1","run_date":"2026-04-28T17:12:38","timeline":{"discoveries":[{"year":2007,"finding":"BCORL1 (BCoR-L1) functions as a transcriptional corepressor that associates with Class II HDACs (HDAC4, HDAC5, HDAC7) and interacts with the CtBP corepressor through a CtBP-interacting motif in its amino terminus; abrogation of the CtBP binding site partially relieves BCORL1-mediated transcriptional repression, and knockdown of BCORL1 derepresses E-cadherin at an endogenous CtBP target promoter.","method":"Co-immunoprecipitation, reporter assay, RNAi knockdown, chromatin localization","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP, mutagenesis of binding motif, and functional RNAi rescue with endogenous target; multiple orthogonal methods in one study","pmids":["17379597"],"is_preprint":false},{"year":2016,"finding":"BCORL1 forms a heterodimer with PCGF1 via its PUFD domain, and this BCORL1/PCGF1 heterodimer is essential for recruiting the KDM2B/SKP1 heterodimer into the non-canonical PRC1.1 complex at CpG islands; the BCORL1 PUFD domain positions residues preceding the RAWUL domain of PCGF1 to create an extended interface unique to PRC1.1.","method":"Crystal structure of KDM2B/SKP1/BCORL1/PCGF1 complex, in vitro assembly assays, domain mapping","journal":"Structure (London, England : 1993)","confidence":"High","confidence_rationale":"Tier 1 — crystal structure combined with in vitro reconstitution and domain dissection","pmids":["27568929"],"is_preprint":false},{"year":2022,"finding":"Recurrent mutations in BCORL1 disrupt assembly of the non-canonical PRC1.1 complex by unlinking the RING-PCGF enzymatic core from the chromatin-targeting auxiliary subcomplex; mutant BCORL1 leaves PRC1.1 localized to chromatin but lacking repressive H2A-ubiquitinating activity, resulting in epigenetic reprogramming and transcriptional activation of oncogenic signaling targets.","method":"Genetic loss-of-function (patient mutations), chromatin immunoprecipitation, transcriptomic analysis, primary patient samples","journal":"Blood cancer discovery","confidence":"High","confidence_rationale":"Tier 2 — epistasis/complex disruption shown with multiple orthogonal methods (ChIP, transcriptomics, patient samples) and mechanistic pathway placement","pmids":["35015684"],"is_preprint":false},{"year":2020,"finding":"Bcorl1 knockout mice are infertile with impaired spermatogenesis; Bcorl1 loss-of-function causes impaired sperm motility and abnormal mitochondrial structure in sperm cells, and knockdown of Bcorl1 in mouse spermatogonial stem cells inhibits SSC self-renewal in vitro.","method":"CRISPR-Cas9 knockout mouse, siRNA knockdown, in vitro SSC culture","journal":"Journal of medical genetics","confidence":"High","confidence_rationale":"Tier 2 — clean KO mouse with defined cellular phenotypes, corroborated by in vitro knockdown","pmids":["32376790"],"is_preprint":false},{"year":2024,"finding":"A loss-of-function variant in BCORL1 (p.Glu522*) produces a truncated protein with altered cellular localization and a dysfunctional interaction with SKP1 (S-phase kinase-associated protein 1), linking BCORL1 to the SKP1 interaction within PRC1.1 and to spermatogenesis.","method":"Whole-exome sequencing, functional assay with recombinant truncated protein, co-immunoprecipitation for SKP1 interaction","journal":"Clinical genetics","confidence":"Medium","confidence_rationale":"Tier 3 — single lab, single Co-IP/localization assay for the SKP1 interaction with partial functional follow-up","pmids":["38342987"],"is_preprint":false},{"year":2024,"finding":"BCORL1 missense variants associated with oligoasthenoteratozoospermia disrupt interaction of BCORL1 with histone deacetylases (HDACs), accompanied by epigenetic alterations and dysregulated transcription of spermatogenetic genes.","method":"Recombinant plasmid expression in cells, interaction assay, transcriptomic analysis","journal":"Andrology","confidence":"Medium","confidence_rationale":"Tier 3 — single lab, in vitro interaction and transcriptomic data supporting mechanism but limited orthogonal validation","pmids":["39189935"],"is_preprint":false},{"year":2018,"finding":"A missense mutation in BCORL1 (Q1076H) found in vemurafenib-resistant melanoma cells contributes to drug resistance; endogenous BCORL1 silencing or ectopic expression of BCORL1Q1076H both mimic the resistance phenotype conferred by CRISPR-edited BCORL1Q1076H, suggesting a mixture of loss- and gain-of-function effects.","method":"CRISPR/Cas9 editing, siRNA silencing, ectopic overexpression, transcriptomic analysis","journal":"Neoplasia (New York, N.Y.)","confidence":"Medium","confidence_rationale":"Tier 2 — multiple genetic perturbations (CRISPR, siRNA, OE) with consistent phenotype, but mechanism is partially defined","pmids":["29605720"],"is_preprint":false}],"current_model":"BCORL1 is a transcriptional corepressor that, via its PUFD domain, forms a heterodimer with PCGF1 to nucleate the non-canonical PRC1.1 Polycomb complex at CpG islands; it also directly binds CtBP through an N-terminal motif and recruits Class II HDACs to repress target genes, and loss-of-function mutations in BCORL1 unlink the PRC1.1 repressive enzymatic core from chromatin-targeting, causing epigenetic de-repression of oncogenic signaling programs in leukemia and defective spermatogenesis in vivo."},"narrative":{"teleology":[{"year":2007,"claim":"Establishing that BCORL1 is a bona fide transcriptional corepressor resolved its molecular activity: it directly binds CtBP through an N-terminal motif, recruits Class II HDACs, and represses endogenous CtBP target genes such as E-cadherin.","evidence":"Co-immunoprecipitation, GAL4-reporter repression assay, CtBP-binding motif mutagenesis, and RNAi knockdown showing E-cadherin derepression in human cell lines","pmids":["17379597"],"confidence":"High","gaps":["Genome-wide target gene repertoire beyond E-cadherin was not defined","Whether BCORL1's HDAC recruitment is direct or bridged through CtBP was not resolved","Relationship to Polycomb complexes was unknown"]},{"year":2016,"claim":"Structural determination of the KDM2B/SKP1/BCORL1/PCGF1 quaternary complex revealed that BCORL1 heterodimerizes with PCGF1 via its PUFD domain to nucleate the non-canonical PRC1.1 complex, explaining how the chromatin-targeting module is assembled at CpG islands.","evidence":"X-ray crystal structure of the four-subunit complex complemented by in vitro reconstitution and domain mapping","pmids":["27568929"],"confidence":"High","gaps":["How the BCORL1-PCGF1 heterodimer communicates with the RING1B-PCGF1 catalytic module on chromatin was not addressed","Whether the CtBP-binding and PRC1.1-nucleating functions of BCORL1 operate on the same or distinct target loci was not tested","In vivo physiological consequences of BCORL1 disruption remained unknown"]},{"year":2018,"claim":"A missense BCORL1 mutation (Q1076H) in vemurafenib-resistant melanoma indicated that BCORL1 perturbation can reprogram transcriptional states relevant to drug resistance, broadening its functional significance beyond development.","evidence":"CRISPR/Cas9 editing, siRNA silencing, and ectopic overexpression in melanoma cells with transcriptomic profiling","pmids":["29605720"],"confidence":"Medium","gaps":["Whether the Q1076H mutation disrupts PRC1.1 assembly or CtBP/HDAC interactions was not determined","The gain-of-function versus loss-of-function dichotomy was not mechanistically resolved","Findings derive from a single cell-line system"]},{"year":2020,"claim":"Bcorl1 knockout mice revealed an essential in vivo role in spermatogenesis, demonstrating that loss of BCORL1 impairs sperm motility, disrupts mitochondrial ultrastructure, and compromises spermatogonial stem cell self-renewal.","evidence":"CRISPR-Cas9 knockout mouse model with phenotyping, corroborated by siRNA knockdown in cultured spermatogonial stem cells","pmids":["32376790"],"confidence":"High","gaps":["Whether the spermatogenesis defect is attributable to loss of PRC1.1 function, HDAC recruitment, or both was not dissected","Downstream transcriptional targets mediating the spermatogenic phenotype were not identified","Female reproductive consequences were not examined"]},{"year":2022,"claim":"Analysis of recurrent BCORL1 mutations in leukemia demonstrated the precise molecular consequence: mutant BCORL1 uncouples the PRC1.1 RING-PCGF catalytic core from the chromatin-targeting auxiliary subcomplex, ablating H2A ubiquitination and de-repressing oncogenic programs.","evidence":"Patient mutation analysis combined with ChIP and transcriptomics in primary leukemia samples","pmids":["35015684"],"confidence":"High","gaps":["Whether pharmacological restoration of PRC1.1 activity can reverse the oncogenic program was not tested","Structural basis for how specific mutations disrupt subcomplex coupling was not resolved at atomic resolution","Contribution of CtBP/HDAC-dependent repression loss to leukemogenesis was not separated from PRC1.1 loss"]},{"year":2024,"claim":"Human BCORL1 variants causing truncation or missense changes were linked to male infertility by disrupting specific protein interactions (SKP1, HDACs) and altering epigenetic control of spermatogenetic genes, providing a molecular bridge between the structural and physiological findings.","evidence":"Whole-exome sequencing of infertile men, co-immunoprecipitation for SKP1 interaction, and transcriptomic analysis of HDAC-disrupting variants","pmids":["38342987","39189935"],"confidence":"Medium","gaps":["Each study represents a single-lab finding with limited cohort size","Whether these variants also predispose to hematologic malignancy is unknown","The relative contributions of PRC1.1 disruption versus HDAC disruption to the infertility phenotype are not delineated"]},{"year":null,"claim":"It remains unresolved how BCORL1's two corepressor arms — PRC1.1 nucleation and CtBP/HDAC recruitment — are coordinated at the genome level, and whether they converge on overlapping or distinct target gene sets in different cell types.","evidence":"","pmids":[],"confidence":"Low","gaps":["No genome-wide chromatin occupancy map of BCORL1 distinguishing PRC1.1-dependent versus CtBP/HDAC-dependent targets exists","Structural basis for how leukemia-associated mutations specifically disrupt the catalytic-to-targeting subcomplex interface has not been determined at atomic resolution","Whether BCORL1 and its paralog BCOR are functionally redundant in specific tissues has not been systematically tested"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,2]},{"term_id":"GO:0042393","term_label":"histone binding","supporting_discovery_ids":[1,2]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,1,2]}],"pathway":[{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[1,2,5]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,2]}],"complexes":["PRC1.1 (non-canonical Polycomb repressive complex 1.1)"],"partners":["PCGF1","KDM2B","SKP1","CTBP1","HDAC4","HDAC5","HDAC7"],"other_free_text":[]},"mechanistic_narrative":"BCORL1 is a transcriptional corepressor that operates through two distinct repressive mechanisms: it nucleates the non-canonical Polycomb repressive complex PRC1.1 by heterodimerizing with PCGF1 via its PUFD domain to recruit the KDM2B/SKP1 chromatin-targeting subcomplex to CpG islands [PMID:27568929], and it independently binds the CtBP corepressor through an N-terminal motif and recruits Class II HDACs (HDAC4, HDAC5, HDAC7) to silence target genes such as E-cadherin [PMID:17379597]. Recurrent loss-of-function mutations in BCORL1 uncouple the PRC1.1 RING-PCGF enzymatic core from its chromatin-targeting module, abolishing H2A-ubiquitinating activity and causing epigenetic de-repression of oncogenic signaling programs in leukemia [PMID:35015684]. BCORL1 is also required for spermatogenesis: knockout mice are infertile with defective sperm motility, abnormal mitochondrial ultrastructure, and impaired spermatogonial stem cell self-renewal, and human BCORL1 variants that disrupt HDAC or SKP1 interactions are associated with oligoasthenoteratozoospermia [PMID:32376790, PMID:38342987, PMID:39189935]."},"prefetch_data":{"uniprot":{"accession":"Q5H9F3","full_name":"BCL-6 corepressor-like protein 1","aliases":[],"length_aa":1785,"mass_kda":190.6,"function":"Transcriptional corepressor. May specifically inhibit gene expression when recruited to promoter regions by sequence-specific DNA-binding proteins such as BCL6. This repression may be mediated at least in part by histone deacetylase activities which can associate with this corepressor","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q5H9F3/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/BCORL1","classification":"Not Classified","n_dependent_lines":9,"n_total_lines":1208,"dependency_fraction":0.0074503311258278145},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"HIST2H2BE","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/BCORL1","total_profiled":1310},"omim":[{"mim_id":"617543","title":"POLYCOMB GROUP RING FINGER PROTEIN 3; PCGF3","url":"https://www.omim.org/entry/617543"},{"mim_id":"610231","title":"POLYCOMB GROUP RING FINGER PROTEIN 1; PCGF1","url":"https://www.omim.org/entry/610231"},{"mim_id":"301029","title":"SHUKLA-VERNON SYNDROME; SHUVER","url":"https://www.omim.org/entry/301029"},{"mim_id":"300688","title":"BCL6 COREPRESSOR-LIKE 1; BCORL1","url":"https://www.omim.org/entry/300688"},{"mim_id":"300608","title":"DACHSHUND FAMILY TRANSCRIPTION FACTOR 2; DACH2","url":"https://www.omim.org/entry/300608"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"},{"location":"Plasma membrane","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in many","driving_tissues":[],"url":"https://www.proteinatlas.org/search/BCORL1"},"hgnc":{"alias_symbol":["FLJ11362","BCoR-L1"],"prev_symbol":["CXorf10"]},"alphafold":{"accession":"Q5H9F3","domains":[{"cath_id":"1.25.40.20","chopping":"1429-1550_1559-1577","consensus_level":"medium","plddt":78.1621,"start":1429,"end":1577},{"cath_id":"3.10.260.40","chopping":"1595-1668_1683-1711","consensus_level":"medium","plddt":74.093,"start":1595,"end":1711}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q5H9F3","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q5H9F3-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q5H9F3-F1-predicted_aligned_error_v6.png","plddt_mean":38.47},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=BCORL1","jax_strain_url":"https://www.jax.org/strain/search?query=BCORL1"},"sequence":{"accession":"Q5H9F3","fasta_url":"https://rest.uniprot.org/uniprotkb/Q5H9F3.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q5H9F3/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q5H9F3"}},"corpus_meta":[{"pmid":"24047651","id":"PMC_24047651","title":"BCOR and BCORL1 mutations in myelodysplastic syndromes and related disorders.","date":"2013","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/24047651","citation_count":171,"is_preprint":false},{"pmid":"17379597","id":"PMC_17379597","title":"A novel corepressor, BCoR-L1, represses transcription through an interaction with CtBP.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17379597","citation_count":72,"is_preprint":false},{"pmid":"21989985","id":"PMC_21989985","title":"Somatic mutations in the transcriptional corepressor gene BCORL1 in adult acute myelogenous leukemia.","date":"2011","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/21989985","citation_count":59,"is_preprint":false},{"pmid":"27537276","id":"PMC_27537276","title":"Expanding the molecular signature of ossifying fibromyxoid tumors with two novel gene fusions: CREBBP-BCORL1 and KDM2A-WWTR1.","date":"2016","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/27537276","citation_count":56,"is_preprint":false},{"pmid":"27568929","id":"PMC_27568929","title":"KDM2B Recruitment of the Polycomb Group Complex, PRC1.1, Requires Cooperation between PCGF1 and BCORL1.","date":"2016","source":"Structure (London, England : 1993)","url":"https://pubmed.ncbi.nlm.nih.gov/27568929","citation_count":49,"is_preprint":false},{"pmid":"35015684","id":"PMC_35015684","title":"BCOR and BCORL1 Mutations Drive Epigenetic Reprogramming and Oncogenic Signaling by Unlinking PRC1.1 from Target Genes.","date":"2022","source":"Blood cancer discovery","url":"https://pubmed.ncbi.nlm.nih.gov/35015684","citation_count":36,"is_preprint":false},{"pmid":"28331900","id":"PMC_28331900","title":"A recurrent endometrial stromal sarcoma harbors the novel fusion JAZF1-BCORL1.","date":"2017","source":"Gynecologic oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/28331900","citation_count":34,"is_preprint":false},{"pmid":"34302054","id":"PMC_34302054","title":"Clinicopathological and genomic characterization of BCORL1-driven high-grade endometrial stromal sarcomas.","date":"2021","source":"Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc","url":"https://pubmed.ncbi.nlm.nih.gov/34302054","citation_count":32,"is_preprint":false},{"pmid":"35499168","id":"PMC_35499168","title":"Endometrial Stromal Sarcomas With BCOR Internal Tandem Duplication and Variant BCOR/BCORL1 Rearrangements Resemble High-grade Endometrial Stromal Sarcomas With Recurrent CDK4 Pathway Alterations and MDM2 Amplifications.","date":"2022","source":"The American journal of surgical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/35499168","citation_count":27,"is_preprint":false},{"pmid":"32376790","id":"PMC_32376790","title":"Human X chromosome exome sequencing identifies BCORL1 as contributor to spermatogenesis.","date":"2020","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/32376790","citation_count":21,"is_preprint":false},{"pmid":"30941876","id":"PMC_30941876","title":"Variants in the transcriptional corepressor BCORL1 are associated with an X-linked disorder of intellectual disability, dysmorphic features, and behavioral abnormalities.","date":"2019","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/30941876","citation_count":20,"is_preprint":false},{"pmid":"29605720","id":"PMC_29605720","title":"Concomitant BCORL1 and BRAF Mutations in Vemurafenib-Resistant Melanoma Cells.","date":"2018","source":"Neoplasia (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/29605720","citation_count":15,"is_preprint":false},{"pmid":"35596897","id":"PMC_35596897","title":"Diffusely infiltrating glioma with CREBBP-BCORL1 fusion showing overexpression of not only BCORL1 but BCOR: A case report.","date":"2022","source":"Brain tumor pathology","url":"https://pubmed.ncbi.nlm.nih.gov/35596897","citation_count":11,"is_preprint":false},{"pmid":"36639698","id":"PMC_36639698","title":"Differential diagnosis of uterine adenosarcoma: identification of JAZF1-BCORL1 rearrangement by comprehensive cancer genomic profiling.","date":"2023","source":"Diagnostic pathology","url":"https://pubmed.ncbi.nlm.nih.gov/36639698","citation_count":7,"is_preprint":false},{"pmid":"33810051","id":"PMC_33810051","title":"Shukla-Vernon Syndrome: A Second Family with a Novel Variant in the BCORL1 Gene.","date":"2021","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/33810051","citation_count":7,"is_preprint":false},{"pmid":"38216991","id":"PMC_38216991","title":"CNS tumor with CREBBP::BCORL1 Fusion and pathogenic mutations in BCOR and CREBBP: expanding the spectrum of BCOR-altered tumors.","date":"2024","source":"Acta neuropathologica communications","url":"https://pubmed.ncbi.nlm.nih.gov/38216991","citation_count":7,"is_preprint":false},{"pmid":"17697391","id":"PMC_17697391","title":"BCoR-L1 variation and breast cancer.","date":"2007","source":"Breast cancer research : BCR","url":"https://pubmed.ncbi.nlm.nih.gov/17697391","citation_count":6,"is_preprint":false},{"pmid":"38637838","id":"PMC_38637838","title":"BCOR::CREBBP fusion in malignant neuroepithelial tumor of CNS expands the spectrum of methylation class CNS tumor with BCOR/BCOR(L1)-fusion.","date":"2024","source":"Acta neuropathologica communications","url":"https://pubmed.ncbi.nlm.nih.gov/38637838","citation_count":5,"is_preprint":false},{"pmid":"35838627","id":"PMC_35838627","title":"An Unusual Benign Uterine Stromal Spindle Cell Tumor Harboring JAZF1::BCORL1.","date":"2022","source":"International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists","url":"https://pubmed.ncbi.nlm.nih.gov/35838627","citation_count":4,"is_preprint":false},{"pmid":"38342987","id":"PMC_38342987","title":"A hemizygous loss-of-function variant in BCORL1 is associated with male infertility and oligoasthenoteratozoospermia.","date":"2024","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/38342987","citation_count":4,"is_preprint":false},{"pmid":"38995507","id":"PMC_38995507","title":"BCORL1, POF1B, and USP9X copy number variation in women with idiopathic diminished ovarian reserve.","date":"2024","source":"Journal of assisted reproduction and genetics","url":"https://pubmed.ncbi.nlm.nih.gov/38995507","citation_count":3,"is_preprint":false},{"pmid":"40202539","id":"PMC_40202539","title":"Impact of BCOR/BCORL1 mutation on outcomes of allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia patients.","date":"2025","source":"Annals of hematology","url":"https://pubmed.ncbi.nlm.nih.gov/40202539","citation_count":2,"is_preprint":false},{"pmid":"39189935","id":"PMC_39189935","title":"Novel and recurrent hemizygous variants in BCORL1 cause oligoasthenoteratozoospermia by interfering transcription.","date":"2024","source":"Andrology","url":"https://pubmed.ncbi.nlm.nih.gov/39189935","citation_count":1,"is_preprint":false},{"pmid":"36324816","id":"PMC_36324816","title":"BCORL1 S878G, GNB1 G116S, SH2B3 A536T, and KMT2D S3708R tetramutation co-contribute to a pediatric acute myeloid leukemia: Case report and literature review.","date":"2022","source":"Frontiers in pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/36324816","citation_count":1,"is_preprint":false},{"pmid":"32606114","id":"PMC_32606114","title":"Case of aggressive metastatic follicular variant papillary thyroid carcinoma with BRAF K601E and BCORL1 mutations.","date":"2020","source":"BMJ case reports","url":"https://pubmed.ncbi.nlm.nih.gov/32606114","citation_count":1,"is_preprint":false},{"pmid":"40805145","id":"PMC_40805145","title":"BCOR, BCORL1, and BCL6 Mutations in Pediatric Leukemias.","date":"2025","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/40805145","citation_count":1,"is_preprint":false},{"pmid":"40724977","id":"PMC_40724977","title":"CNS Tumor with BCOR/BCORL1 Fusion: A Rare Tumor Entity.","date":"2025","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/40724977","citation_count":0,"is_preprint":false},{"pmid":"32776737","id":"PMC_32776737","title":"Age-Related Co-Expression of BCOR and BCORL1 mRNA in Acute Myeloid Leukemia.","date":"2020","source":"Clinical laboratory","url":"https://pubmed.ncbi.nlm.nih.gov/32776737","citation_count":0,"is_preprint":false},{"pmid":"41787467","id":"PMC_41787467","title":"Epigenetic corepressor BCORL1 predominates as a driver of clonal hematopoiesis of indeterminate potential in patients undergoing chronic hemodialysis: a multicenter cohort study.","date":"2026","source":"Human genomics","url":"https://pubmed.ncbi.nlm.nih.gov/41787467","citation_count":0,"is_preprint":false},{"pmid":"40466561","id":"PMC_40466561","title":"The association between XRCC2 and BCORL1 expression with sperm DNA fragmentation index in infertile men candidates undergoing intracytoplasmic sperm injection (ICSI).","date":"2025","source":"Tissue & cell","url":"https://pubmed.ncbi.nlm.nih.gov/40466561","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":17422,"output_tokens":1829,"usd":0.03985},"stage2":{"model":"claude-opus-4-6","input_tokens":5083,"output_tokens":2343,"usd":0.125985},"total_usd":0.165835,"stage1_batch_id":"msgbatch_01TqNM6p6FsoMBT2jzQTwKBr","stage2_batch_id":"msgbatch_01Ya473eco8sTHbvRymQaU8o","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2007,\n      \"finding\": \"BCORL1 (BCoR-L1) functions as a transcriptional corepressor that associates with Class II HDACs (HDAC4, HDAC5, HDAC7) and interacts with the CtBP corepressor through a CtBP-interacting motif in its amino terminus; abrogation of the CtBP binding site partially relieves BCORL1-mediated transcriptional repression, and knockdown of BCORL1 derepresses E-cadherin at an endogenous CtBP target promoter.\",\n      \"method\": \"Co-immunoprecipitation, reporter assay, RNAi knockdown, chromatin localization\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP, mutagenesis of binding motif, and functional RNAi rescue with endogenous target; multiple orthogonal methods in one study\",\n      \"pmids\": [\"17379597\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"BCORL1 forms a heterodimer with PCGF1 via its PUFD domain, and this BCORL1/PCGF1 heterodimer is essential for recruiting the KDM2B/SKP1 heterodimer into the non-canonical PRC1.1 complex at CpG islands; the BCORL1 PUFD domain positions residues preceding the RAWUL domain of PCGF1 to create an extended interface unique to PRC1.1.\",\n      \"method\": \"Crystal structure of KDM2B/SKP1/BCORL1/PCGF1 complex, in vitro assembly assays, domain mapping\",\n      \"journal\": \"Structure (London, England : 1993)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure combined with in vitro reconstitution and domain dissection\",\n      \"pmids\": [\"27568929\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Recurrent mutations in BCORL1 disrupt assembly of the non-canonical PRC1.1 complex by unlinking the RING-PCGF enzymatic core from the chromatin-targeting auxiliary subcomplex; mutant BCORL1 leaves PRC1.1 localized to chromatin but lacking repressive H2A-ubiquitinating activity, resulting in epigenetic reprogramming and transcriptional activation of oncogenic signaling targets.\",\n      \"method\": \"Genetic loss-of-function (patient mutations), chromatin immunoprecipitation, transcriptomic analysis, primary patient samples\",\n      \"journal\": \"Blood cancer discovery\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — epistasis/complex disruption shown with multiple orthogonal methods (ChIP, transcriptomics, patient samples) and mechanistic pathway placement\",\n      \"pmids\": [\"35015684\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Bcorl1 knockout mice are infertile with impaired spermatogenesis; Bcorl1 loss-of-function causes impaired sperm motility and abnormal mitochondrial structure in sperm cells, and knockdown of Bcorl1 in mouse spermatogonial stem cells inhibits SSC self-renewal in vitro.\",\n      \"method\": \"CRISPR-Cas9 knockout mouse, siRNA knockdown, in vitro SSC culture\",\n      \"journal\": \"Journal of medical genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO mouse with defined cellular phenotypes, corroborated by in vitro knockdown\",\n      \"pmids\": [\"32376790\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"A loss-of-function variant in BCORL1 (p.Glu522*) produces a truncated protein with altered cellular localization and a dysfunctional interaction with SKP1 (S-phase kinase-associated protein 1), linking BCORL1 to the SKP1 interaction within PRC1.1 and to spermatogenesis.\",\n      \"method\": \"Whole-exome sequencing, functional assay with recombinant truncated protein, co-immunoprecipitation for SKP1 interaction\",\n      \"journal\": \"Clinical genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single lab, single Co-IP/localization assay for the SKP1 interaction with partial functional follow-up\",\n      \"pmids\": [\"38342987\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"BCORL1 missense variants associated with oligoasthenoteratozoospermia disrupt interaction of BCORL1 with histone deacetylases (HDACs), accompanied by epigenetic alterations and dysregulated transcription of spermatogenetic genes.\",\n      \"method\": \"Recombinant plasmid expression in cells, interaction assay, transcriptomic analysis\",\n      \"journal\": \"Andrology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single lab, in vitro interaction and transcriptomic data supporting mechanism but limited orthogonal validation\",\n      \"pmids\": [\"39189935\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"A missense mutation in BCORL1 (Q1076H) found in vemurafenib-resistant melanoma cells contributes to drug resistance; endogenous BCORL1 silencing or ectopic expression of BCORL1Q1076H both mimic the resistance phenotype conferred by CRISPR-edited BCORL1Q1076H, suggesting a mixture of loss- and gain-of-function effects.\",\n      \"method\": \"CRISPR/Cas9 editing, siRNA silencing, ectopic overexpression, transcriptomic analysis\",\n      \"journal\": \"Neoplasia (New York, N.Y.)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple genetic perturbations (CRISPR, siRNA, OE) with consistent phenotype, but mechanism is partially defined\",\n      \"pmids\": [\"29605720\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"BCORL1 is a transcriptional corepressor that, via its PUFD domain, forms a heterodimer with PCGF1 to nucleate the non-canonical PRC1.1 Polycomb complex at CpG islands; it also directly binds CtBP through an N-terminal motif and recruits Class II HDACs to repress target genes, and loss-of-function mutations in BCORL1 unlink the PRC1.1 repressive enzymatic core from chromatin-targeting, causing epigenetic de-repression of oncogenic signaling programs in leukemia and defective spermatogenesis in vivo.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"BCORL1 is a transcriptional corepressor that operates through two distinct repressive mechanisms: it nucleates the non-canonical Polycomb repressive complex PRC1.1 by heterodimerizing with PCGF1 via its PUFD domain to recruit the KDM2B/SKP1 chromatin-targeting subcomplex to CpG islands [PMID:27568929], and it independently binds the CtBP corepressor through an N-terminal motif and recruits Class II HDACs (HDAC4, HDAC5, HDAC7) to silence target genes such as E-cadherin [PMID:17379597]. Recurrent loss-of-function mutations in BCORL1 uncouple the PRC1.1 RING-PCGF enzymatic core from its chromatin-targeting module, abolishing H2A-ubiquitinating activity and causing epigenetic de-repression of oncogenic signaling programs in leukemia [PMID:35015684]. BCORL1 is also required for spermatogenesis: knockout mice are infertile with defective sperm motility, abnormal mitochondrial ultrastructure, and impaired spermatogonial stem cell self-renewal, and human BCORL1 variants that disrupt HDAC or SKP1 interactions are associated with oligoasthenoteratozoospermia [PMID:32376790, PMID:38342987, PMID:39189935].\",\n  \"teleology\": [\n    {\n      \"year\": 2007,\n      \"claim\": \"Establishing that BCORL1 is a bona fide transcriptional corepressor resolved its molecular activity: it directly binds CtBP through an N-terminal motif, recruits Class II HDACs, and represses endogenous CtBP target genes such as E-cadherin.\",\n      \"evidence\": \"Co-immunoprecipitation, GAL4-reporter repression assay, CtBP-binding motif mutagenesis, and RNAi knockdown showing E-cadherin derepression in human cell lines\",\n      \"pmids\": [\"17379597\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Genome-wide target gene repertoire beyond E-cadherin was not defined\",\n        \"Whether BCORL1's HDAC recruitment is direct or bridged through CtBP was not resolved\",\n        \"Relationship to Polycomb complexes was unknown\"\n      ]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Structural determination of the KDM2B/SKP1/BCORL1/PCGF1 quaternary complex revealed that BCORL1 heterodimerizes with PCGF1 via its PUFD domain to nucleate the non-canonical PRC1.1 complex, explaining how the chromatin-targeting module is assembled at CpG islands.\",\n      \"evidence\": \"X-ray crystal structure of the four-subunit complex complemented by in vitro reconstitution and domain mapping\",\n      \"pmids\": [\"27568929\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"How the BCORL1-PCGF1 heterodimer communicates with the RING1B-PCGF1 catalytic module on chromatin was not addressed\",\n        \"Whether the CtBP-binding and PRC1.1-nucleating functions of BCORL1 operate on the same or distinct target loci was not tested\",\n        \"In vivo physiological consequences of BCORL1 disruption remained unknown\"\n      ]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"A missense BCORL1 mutation (Q1076H) in vemurafenib-resistant melanoma indicated that BCORL1 perturbation can reprogram transcriptional states relevant to drug resistance, broadening its functional significance beyond development.\",\n      \"evidence\": \"CRISPR/Cas9 editing, siRNA silencing, and ectopic overexpression in melanoma cells with transcriptomic profiling\",\n      \"pmids\": [\"29605720\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether the Q1076H mutation disrupts PRC1.1 assembly or CtBP/HDAC interactions was not determined\",\n        \"The gain-of-function versus loss-of-function dichotomy was not mechanistically resolved\",\n        \"Findings derive from a single cell-line system\"\n      ]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Bcorl1 knockout mice revealed an essential in vivo role in spermatogenesis, demonstrating that loss of BCORL1 impairs sperm motility, disrupts mitochondrial ultrastructure, and compromises spermatogonial stem cell self-renewal.\",\n      \"evidence\": \"CRISPR-Cas9 knockout mouse model with phenotyping, corroborated by siRNA knockdown in cultured spermatogonial stem cells\",\n      \"pmids\": [\"32376790\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether the spermatogenesis defect is attributable to loss of PRC1.1 function, HDAC recruitment, or both was not dissected\",\n        \"Downstream transcriptional targets mediating the spermatogenic phenotype were not identified\",\n        \"Female reproductive consequences were not examined\"\n      ]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Analysis of recurrent BCORL1 mutations in leukemia demonstrated the precise molecular consequence: mutant BCORL1 uncouples the PRC1.1 RING-PCGF catalytic core from the chromatin-targeting auxiliary subcomplex, ablating H2A ubiquitination and de-repressing oncogenic programs.\",\n      \"evidence\": \"Patient mutation analysis combined with ChIP and transcriptomics in primary leukemia samples\",\n      \"pmids\": [\"35015684\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether pharmacological restoration of PRC1.1 activity can reverse the oncogenic program was not tested\",\n        \"Structural basis for how specific mutations disrupt subcomplex coupling was not resolved at atomic resolution\",\n        \"Contribution of CtBP/HDAC-dependent repression loss to leukemogenesis was not separated from PRC1.1 loss\"\n      ]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Human BCORL1 variants causing truncation or missense changes were linked to male infertility by disrupting specific protein interactions (SKP1, HDACs) and altering epigenetic control of spermatogenetic genes, providing a molecular bridge between the structural and physiological findings.\",\n      \"evidence\": \"Whole-exome sequencing of infertile men, co-immunoprecipitation for SKP1 interaction, and transcriptomic analysis of HDAC-disrupting variants\",\n      \"pmids\": [\"38342987\", \"39189935\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Each study represents a single-lab finding with limited cohort size\",\n        \"Whether these variants also predispose to hematologic malignancy is unknown\",\n        \"The relative contributions of PRC1.1 disruption versus HDAC disruption to the infertility phenotype are not delineated\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unresolved how BCORL1's two corepressor arms — PRC1.1 nucleation and CtBP/HDAC recruitment — are coordinated at the genome level, and whether they converge on overlapping or distinct target gene sets in different cell types.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No genome-wide chromatin occupancy map of BCORL1 distinguishing PRC1.1-dependent versus CtBP/HDAC-dependent targets exists\",\n        \"Structural basis for how leukemia-associated mutations specifically disrupt the catalytic-to-targeting subcomplex interface has not been determined at atomic resolution\",\n        \"Whether BCORL1 and its paralog BCOR are functionally redundant in specific tissues has not been systematically tested\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 2]},\n      {\"term_id\": \"GO:0042393\", \"supporting_discovery_ids\": [1, 2]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 1, 2]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [1, 2, 5]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 2]}\n    ],\n    \"complexes\": [\n      \"PRC1.1 (non-canonical Polycomb repressive complex 1.1)\"\n    ],\n    \"partners\": [\n      \"PCGF1\",\n      \"KDM2B\",\n      \"SKP1\",\n      \"CTBP1\",\n      \"HDAC4\",\n      \"HDAC5\",\n      \"HDAC7\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}